Previous studies have suggested a correlation between high IL-33 expression and poorer survival for GBM patients.33,34 We therefore performed Kaplan–Meier analysis on the overall survival data of the TCGA GBM cohort (The Cancer Genome Atlas, www.cancer.gov). Here, IL33 is linked to glioblastoma.